Urteste Valuation
Is URT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of URT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate URT's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate URT's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for URT?
Key metric: As URT is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is URT's PB Ratio? | |
|---|---|
| PB Ratio | 4.4x |
| Book | zł25.86m |
| Market Cap | zł115.03m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | -21.1x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does URT's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 7x | ||
GMT Genomtec | 7.8x | n/a | zł99.0m |
MAB Mabion | 1.5x | -116.7% | zł192.0m |
PTG Poltreg | 2.6x | -22.6% | zł217.8m |
RDG Read-Gene | 16.1x | n/a | zł54.2m |
URT Urteste | 4.4x | n/a | zł115.0m |
Price-To-Book vs Peers: URT is good value based on its Price-To-Book Ratio (4.4x) compared to the peer average (7x).
Price to Book Ratio vs Industry
How does URT's PB Ratio compare vs other companies in the European Biotechs Industry?
| 24 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 24 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: URT is expensive based on its Price-To-Book Ratio (4.4x) compared to the European Biotechs industry average (2.3x).
Price to Book Ratio vs Fair Ratio
What is URT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 4.4x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate URT's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.